Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BLACNASDAQ:OSRHOTCMKTS:SIGYOTCMKTS:UMGP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLACBellevue Life Sciences Acquisition$1.54-4.9%$1.34$3.01▼$13.40$6.22M-0.0820,837 shs194,958 shsOSRHOSR$1.31-14.9%$1.34$1.02▼$13.40$29.69M1.6196,909 shs216,322 shsSIGYSigyn Therapeutics$2.75$3.30$2.49▼$5.75$4.41M-1.18140 shsN/AUMGPDalton Industries$0.03-0.4%$0.03$0.02▼$0.29$980K-0.022,602 shs1,200 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLACBellevue Life Sciences Acquisition0.00%+9.22%+32.76%-9.94%-85.67%OSRHOSR-14.94%-14.38%+12.93%-18.13%+130,999,900.00%SIGYSigyn Therapeutics0.00%0.00%-22.10%-31.25%-47.62%UMGPDalton Industries-0.38%-19.70%+1.92%-1.85%-78.80%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AOSRHOSRN/AN/AN/AN/AN/AN/AN/AN/ASIGYSigyn TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AUMGPDalton IndustriesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLACBellevue Life Sciences Acquisition 0.00N/AN/AN/AOSRHOSR 0.00N/AN/AN/ASIGYSigyn Therapeutics 0.00N/AN/AN/AUMGPDalton Industries 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/AN/AOSRHOSRN/AN/AN/AN/A($3.87) per shareN/ASIGYSigyn TherapeuticsN/AN/AN/AN/A($2.78) per shareN/AUMGPDalton Industries$30K32.51N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLACBellevue Life Sciences AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/AOSRHOSR-$2.41MN/A0.00∞N/AN/AN/AN/AN/ASIGYSigyn Therapeutics-$3.34M-$4.57N/A∞N/AN/AN/A-2,014.27%N/AUMGPDalton Industries-$350K-$0.01N/A∞N/AN/AN/AN/AN/ALatest UMGP, OSRH, SIGY, and BLAC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q1 2025OSRHOSRN/A-$1.04N/A-$1.04N/A$0.76 million5/20/2025Q1 2025SIGYSigyn TherapeuticsN/A-$0.42N/A-$0.42N/AN/A4/15/2025Q4 2024SIGYSigyn TherapeuticsN/A-$2.51N/A-$2.51N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/AOSRHOSRN/AN/AN/AN/AN/ASIGYSigyn TherapeuticsN/AN/AN/AN/AN/AUMGPDalton IndustriesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLACBellevue Life Sciences AcquisitionN/AN/AN/AOSRHOSRN/A0.070.07SIGYSigyn TherapeuticsN/A0.010.01UMGPDalton IndustriesN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLACBellevue Life Sciences Acquisition55.30%OSRHOSR55.30%SIGYSigyn Therapeutics10.01%UMGPDalton IndustriesN/AInsider OwnershipCompanyInsider OwnershipBLACBellevue Life Sciences Acquisition33.67%OSRHOSR33.67%SIGYSigyn Therapeutics78.46%UMGPDalton IndustriesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLACBellevue Life Sciences AcquisitionN/A4.04 million2.68 millionNot OptionableOSRHOSRN/A19.28 million12.79 millionN/ASIGYSigyn Therapeutics51.61 million346,000Not OptionableUMGPDalton Industries2436.80 millionN/ANot OptionableUMGP, OSRH, SIGY, and BLAC HeadlinesRecent News About These CompaniesContrasting TELA Bio (NASDAQ:TELA) & Universal Media Group (OTCMKTS:UMGP)June 17, 2025 | americanbankingnews.comPatrick Whitesell’s New Investment Firm WTSL Launches A New J.V. With UMGJune 14, 2025 | celebrityaccess.comUMG & Ex-Endeavor Exec Patrick Whitesell Form Joint Venture to Extend Artists’ IP Beyond MusicJune 14, 2025 | billboard.comUMG JV with investment firm WTSL focuses on ‘artist-led IP’June 13, 2025 | musically.comUniversal Music and Hollywood agent Patrick Whitesell launch joint venture.. with backing from SilverlakeJune 12, 2025 | musicbusinessworldwide.comPatrick Whitesell Starts Joint Venture With Universal Music GroupJune 12, 2025 | msn.comExecs at YouTube Music, WMG, UMG, VEVO, Roc Nation, Recording Academy & More Denounce Anti-Israel Extremism and AntisemitismMay 30, 2025 | msn.comBeastie Boys, UMG settle lawsuits against Chili’s over ‘Sabotage’ adsMay 23, 2025 | msn.comBeastie Boys and UMG Settle Lawsuits With Chili’s Over ‘Sabotage’ Use in AdsMay 22, 2025 | msn.comPENN 2 Welcomes Universal Music Group in Headquarters MoveMay 22, 2025 | globest.comSalt-N-Pepa sue Universal over ownership of master recordings – UMG says it remains ‘committed to working towards an amicable resolution’May 21, 2025 | musicbusinessworldwide.comSalt-N-Pepa Sue Universal Music Group Over Music Rights and Album RemovalMay 21, 2025 | thesource.comUniversal Music Fires Back Against Salt-N-Pepa’s ‘Unreasonable Demands,’ Says It’s ‘Committed to Working Towards an Amicable Resolution’May 21, 2025 | msn.comUMG and Beastie Boys Settle Lawsuits Against Chili’s Over Social Media AdsMay 21, 2025 | billboard.comUniversal Music Group to Relocate New York Offices to Manhattan’s Penn DistrictMay 21, 2025 | rebusinessonline.comMatt Ellis named Chief Financial Officer of Universal Music GroupMay 13, 2025 | exchange4media.comUniversal Music Group N.V.: UNIVERSAL MUSIC GROUP APPOINTS MATT ELLIS AS CHIEF FINANCIAL OFFICERMay 12, 2025 | finanznachrichten.deUNIVERSAL MUSIC GROUP APPOINTS MATT ELLIS AS CHIEF FINANCIAL OFFICERMay 12, 2025 | finance.yahoo.comUniversal Music Group appoints Matt Ellis as new CFOMay 12, 2025 | investing.comUniversal Music Group Names Matt Ellis Chief Financial OfficerMay 12, 2025 | variety.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeUMGP, OSRH, SIGY, and BLAC Company DescriptionsBellevue Life Sciences Acquisition NASDAQ:BLAC$1.54 -0.08 (-4.94%) As of 06/20/2025Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.OSR NASDAQ:OSRH$1.31 -0.23 (-14.94%) As of 06/23/2025 04:00 PM EasternOSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.Sigyn Therapeutics OTCMKTS:SIGY$2.75 0.00 (0.00%) As of 06/20/2025Sigyn Therapeutics, Inc., a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats. The company is also involved in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. In addition, it develops ChemoPrep to enhance the tumor site delivery of chemotherapy; ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis; and ImmunePrep to enhance the potential efficacy of immunotherapeutic antibodies. Sigyn Therapeutics, Inc. was founded in 2019 and is headquartered in San Diego, California.Dalton Industries OTCMKTS:UMGP$0.03 0.00 (-0.38%) As of 06/23/2025 09:30 AM EasternUniversal Media Group Inc., a media company, produces and distributes media content worldwide. It produces On The Mike, a TV show that primarily include celebrity interviews, music concerts, and other events. The company was formerly known as Dalton Industries Inc. and changed its name to Universal Media Group Inc. in January 2016. Universal Media Group Inc. was founded in 1971 and is based in Boca Raton, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Stock Holds Steady as AI Drives Workforce Shift Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Kroger Stock Confirms Buy Signal as Uptrend Gains Strength Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback Alphabet’s Comeback: The Hidden Engines Powering Google New All-Time Highs Coming for Broadcom? Wall Street Says Yes Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
